Siddesh V. Hartimath
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 5
- Chemokine receptors and signaling 4
-
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 5
-
- Radiopharmaceutical Chemistry and Applications 5
-
- Mosquito-borne diseases and control 4
-
- Cardiovascular Disease and Adiposity 3
- Co-authors
- Erik F. J. de VriesRudi DierckxJulian GoggiEdward G. RobinsAren van WaardeHumphrey FongeBoominathan RamasamyWendy Bernhard
- Journals
- Molecular Imaging and Biology (4 papers)Molecular Pharmaceutics (3 papers)Contrast Media & Molecular Imaging (2 papers)
- Partner nations
- SingaporeCanadaNetherlands
In The Last Decade
Siddesh V. Hartimath
29 papers receiving 431 citations
Peers
Comparison fields: 5 of 61
- Oncology 241
- Immunology 179
- Radiology, Nuclear Medicine and Imaging 126
- Immunology and Allergy 13
- Molecular Biology 89
Countries citing papers authored by Siddesh V. Hartimath
This map shows the geographic impact of Siddesh V. Hartimath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siddesh V. Hartimath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siddesh V. Hartimath more than expected).
Fields of papers citing papers by Siddesh V. Hartimath
This network shows the impact of papers produced by Siddesh V. Hartimath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siddesh V. Hartimath. The network helps show where Siddesh V. Hartimath may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Siddesh V. Hartimath, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2022 | 10 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 23 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 10 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 25 | |
| 12 | 2019 | 23 | |
| 13 | 2019 | 28 | |
| 14 | 2019 | 49 | |
| 15 | 2019 | 30 | |
| 16 | 2018 | 10 | |
| 17 | 2016 | 14 | |
| 18 | 2016 | 47 | |
| 19 | N-[11C] methyl-AMD3465 a new tracer for PET imaging of CXCR4 receptors | 2013 | 0 |
| 20 | 2013 | 29 |
About Siddesh V. Hartimath
Siddesh V. Hartimath is a scholar working on Oncology, Immunology and Virology, having authored 30 papers that have together received 433 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers), CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers), Mosquito-borne diseases and control (4 papers), Chemokine receptors and signaling (4 papers) and Cardiovascular Disease and Adiposity (3 papers). The work is most often cited by research in Oncology (241 citations), Immunology (179 citations) and Radiology, Nuclear Medicine and Imaging (126 citations). Siddesh V. Hartimath has collaborated with scholars based in Singapore, Canada and Netherlands. Frequent co-authors include Erik F. J. de Vries, Rudi Dierckx, Julian Goggi, Edward G. Robins, Aren van Waarde, Humphrey Fonge, Boominathan Ramasamy, Wendy Bernhard, Elahe Alizadeh and C. Ronald Geyer. Their work appears in journals such as Molecular Imaging and Biology, Molecular Pharmaceutics, Contrast Media & Molecular Imaging, Oncotarget and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.